Luminescent 11-{Naphthalen-1-yl}dipyrido[3,2-a:2′,3′-c]phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy

Utpal Das, Shanooja Shanavas, Apoorva H. Nagendra, +7

ACS Applied Bio Materials

G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells

Nilmadhab Roy, Shanooja Shanavas, Binoy Kar, +7

ACS Omega

2-Aryl-1<i>H</i>-imidazo[4,5-<i>f</i>][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents

Binoy Kar, Shanooja Shanavas, Arun Karmakar, +6

Journal of Medicinal Chemistry

Mitochondria-targeted half-sandwich iridium(<scp>iii</scp>)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468

Ashaparna Mondal, Shanooja Shanavas, Utsav Sen, +4

RSC Advances

Mitigation of chronic glucotoxicity-mediated skeletal muscle atrophy by arachidonic acid

Akash Mitra, Shanooja Shanavas, Debajit Chaudhury, +3

Life Sciences

Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment

Utpal Das, Shanooja Shanavas, Meena Jayaprakash, +10

Journal of Medicinal Chemistry

Iridium(<scp>iii</scp>)–Cp*-(imidazo[4,5-<i>f</i>][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents

Binoy Kar, Shanooja Shanavas, Apoorva H. Nagendra, +12

Dalton Transactions

Sialic Acid-Targeted Ru(II)/Ir(III)/Re(I) Complexes for Ferroptosis Induction in Triple-Negative Breast Cancer

Nilmadhab Roy, Tiasha Dasgupta, Sreejani Ghosh, +12

Langmuir